Inventor · disambiguated record
Chunliang Lu
Also filed as: LU CHUNLIANG
16 granted patents·8 pending applications·10 citations·filing 2017–2025
86Inventor score
Files withXEROX CORP14ACONCAGUA BIO INC3JANSSEN SCIENCES IRELAND UNLIMITED CO3GASHERBRUM BIO INC2NOVARTIS AG2
Top patents by PatentIndex Score
24 records- 0192US12291529B2Heterocyclic GLP-1 agonistsGASHERBRUM BIO INC·Filed 2024·Granted May 6, 2025·2 cites·28 claims
- 0291US9958797B1Toner process comprising synthesizing amphiphilic block copolymers via emulsion polymerizationXEROX CORP·Filed 2017·Granted May 1, 2018·6 cites·15 claims
- 0390US11400647B2Utilization of magnetic particles to improve z-axis strength of 3D printed objectsXEROX CORP·Filed 2020·Granted Aug 2, 2022·2 cites·20 claims
- 0483US11952479B2Fluorescent orange latex with enhanced brightness and toners made therefromXEROX CORP·Filed 2022·Granted Apr 9, 2024·0 cites·20 claims
- 0579US11951683B2Utilization of magnetic particles to improve z-axis strength of 3D printed objectsXEROX CORP·Filed 2022·Granted Apr 9, 2024·0 cites·20 claims
- 0674US2024327404A1Heterocyclic glp-1 agonistsGASHERBRUM BIO INC·Filed 2024·Application pending·0 cites
- 0773US12202953B2Fluorescent magenta latex with enhanced brightness and toners made therefromXEROX CORP·Filed 2022·Granted Jan 21, 2025·0 cites·20 claims
- 0865US11643540B2Seeded emulsion polymerization process for latexes and aqueous inkjet ink compositions made therefromXEROX CORP·Filed 2021·Granted May 9, 2023·0 cites·19 claims
- 0965US11453759B2Fluorescent magenta latex with enhanced brightness and toners made therefromXEROX CORP·Filed 2020·Granted Sep 27, 2022·0 cites·14 claims
- 1065US11453760B2Fluorescent orange latex with enhanced brightness and toners made therefromXEROX CORP·Filed 2020·Granted Sep 27, 2022·0 cites·14 claims
- 1162US12486269B2Compounds and compositions for treating conditions associated with calcitonin receptor and/or amylin receptor activityACONCAGUA BIO INC·Filed 2025·Granted Dec 2, 2025·0 cites·26 claims
- 1261US2025011326A1Fused heterocyclic derivatives and their use in the treatment of hbv infectionJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2023·Application pending·0 cites
- 1359US2025042916A1Compounds, compositions, and methodsACONCAGUA BIO INC·Filed 2024·Application pending·0 cites
- 1458US11448981B2Fluorescent latexes with enhanced brightnessXEROX CORP·Filed 2020·Granted Sep 20, 2022·0 cites·14 claims
- 1558US11209741B2Fluorescent green toners with enhanced brightnessXEROX CORP·Filed 2020·Granted Dec 28, 2021·0 cites·20 claims
- 1658US2025051355A1Compounds, compositions, and methodsACONCAGUA BIO INC·Filed 2024·Application pending·0 cites
- 1757US2024279227A1Fused heterocyclic derivativesJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2022·Application pending·0 cites
- 1857US2024287070A1Fused heterocyclic derivativesJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2022·Application pending·0 cites
- 1952US11204562B2Fluorescent pink toners and related methodsXEROX CORP·Filed 2020·Granted Dec 21, 2021·0 cites·12 claims
- 2048US12371434B2MLL1 inhibitors and anti-cancer agentsNOVARTIS AG·Filed 2021·Granted Jul 29, 2025·0 cites·19 claims
- 2147US11199787B2Fluorescent metallic toners and related methodsXEROX CORP·Filed 2020·Granted Dec 14, 2021·0 cites·15 claims
- 2244US11199786B2Fluorescent white toners and related methodsXEROX CORP·Filed 2020·Granted Dec 14, 2021·0 cites·3 claims
- 2343US2022380371A1Mll1 inhibitors and anti-cancer agentsNOVARTIS AG·Filed 2020·Application pending·0 cites
- 2440US2022098374A1Crosslinked fluorescent latexesXEROX CORP·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Chunliang Lu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →